Viemed Healthcare (VMD) Capital Expenditures Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.22% |
| 10 | Viemed Healthcare | 373.53 Mn | 365.70 Mn | 42.83 Mn | -20.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.52% |
| Dec 31, 2025 | -4,052.15% |
| Sep 30, 2025 | 21,057.36% |
| Jun 30, 2025 | 11.11% |
| Mar 31, 2025 | 49.30% |
| Dec 31, 2024 | -5,292.31% |
| Sep 30, 2024 | 105.12% |
| Jun 30, 2024 | 113.78% |
| Mar 31, 2024 | -48.13% |
| Dec 31, 2023 | 100.08% |
| Sep 30, 2023 | -114.64% |
| Jun 30, 2023 | -10,361.90% |
| Mar 31, 2023 | 4,581.00% |
| Dec 31, 2022 | -37.69% |
| Sep 30, 2022 | 114.18% |
| Jun 30, 2022 | -99.58% |
| Dec 31, 2021 | -357.87% |
| Sep 30, 2021 | -1.71% |
| Jun 30, 2021 | 220.48% |
| Dec 31, 2020 | 145.74% |
| Sep 30, 2020 | -22.77% |
| Dec 31, 2019 | -516.45% |
| Sep 30, 2019 | 598.02% |